Recombinant Human PHEX Protein, CF 25 UG

所属行业:生物试剂     有0人感兴趣

Recombinant Human PHEX Protein, CF 25 UG信息二维码

微信扫码

 
基础投资电议
推荐指数
  • 区域全国
  • 留言暂无
  • 浏览0
  • 更新2024-07-25 20:40
  • 到期长期有效






更多>我还有产品
3-Amino-5-methoxycarbonylphenylboronic acid, pinacol ester  1 g 2,3-Dichloro-6-(trifluoromethyl)benzyl bromide  1 g 1-(4-Fluorophenyl)-5-methoxycarbonyl-2(1H)-pyridinone  1 g N,N-Diethyl-cyclohexane-1,4-diamine  1 g N-Methyl-DL-leucine hydrochloride  5 g N-(2-Chloroethyl) 3-boronobenzamide  5 g

产品介绍

    基本参数

    详细说明

    • Purity
      >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane
    • Endotoxin Level
      <0.01 EU per 1 μg of the protein by the LAL method.
    • Activity
      Measured by its ability to cleave a fluorogenic peptide substrate, Mca-YVADAPK. The specific activity is >125 pmol/min/μg, as measured under the described conditions. See Activity Assay Protocol on www.RnDSystems.com
    • Source
      Spodoptera frugiperda, Sf 21 (baculovirus)-derived Gln42-Trp749, with an N-terminal 6-His tag
    • Accession #
    • N-terminal Sequence
      Analysis
      His & Leu47
    • Predicted Molecular Mass
      83 kDa
    • SDS-PAGE
      68-85 kDa, reducing conditions
    8090-ZN
     
    Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
    Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
    Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    • 6 months from date of receipt, -20 to -70 °C as supplied.
    • 3 months, -20 to -70 °C under sterile conditions after opening.
    Assay Procedure
    Materials
    • Assay Buffer:  50 mM MES, 250 mM NaCl, pH 6.0
    • Recombinant Human PHEX (rhPHEX) (Catalog # 8090-ZN)
    • Substrate:  Mca-YVADAPK(Dnp)-OH (Catalog # )
    • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
    • Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
    1. Dilute rhPHEX to 4 ng/µL in Assay Buffer.
    2. Dilute Substrate to 100 µM in Assay Buffer.
    3. Load 50 µL of 4 ng/µL rhPHEX into a plate, and start the reaction by adding 50 µL of 100 µM Substrate. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of Substrate.
    4. Read at excitation and emission wavelengths of 320 nm and 405 nm, respectively in kinetic mode for 5 minutes.
    5. Calculate specific activity:

         Specific Activity (pmol/min/µg) =

    Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
    amount of enzyme (µg)

         *Adjusted for Substrate Blank
         **Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975).

    Per Well:
    • rhPHEX: 0.2 µg
    • Substrate: 50 µM
    Background: PHEX

    PHEX (PHosphate-regulating gene with homology to Endopeptidases on the X-chromosome; also known as metallopeptidase homolog PEX, vitamin D resistant hypophosphatemic rickets protein and X-linked hypophosphatemia protein/HYP) is a monomeric, zinc-dependent transmembrane member of the metallopeptidase M13 family of enzymes (1-6). Members of the M13 family are membrane-bound and characterized by the presence of a catalytic domain that consists of an ExxAG (or D) endopeptidase sequence, coupled to a canonical Zn-binding HExxH motif (1, 3). PHEX expression is limited to a small number of cell types, including mature osteoblasts (7, 8), osteocytes (8, 9), and odontoblasts (but not ameloblasts) (7, 8). PHEX appears to have a material effect on mineralization. Typically, mineralization occurs when inorganic phosphate interacts with calcium to form hydroxyapatite. These crystals are deposited on the surface of either collagen I or DMP1 in bone matrix, and serve as nucleation sites for additional mineral deposition (10, 11). At select timepoints, osteocytes will downregulate the rate of mineralization, principally to insure that space exists between cell processes and calcified matrix. This is accomplished through the secretion of SIBLING family molecules (OPN; MEPE) that possess RGD and ASARM (Acidic Serine-and-Aspartate-Rich Motif) sequences.  When cathepsin-like molecules are available, SIBLING molecules are cleaved, releasing ASARMs. If phosphorylated, these ASARMs bind to naked nucleation sites and terminate the growth of mineral. PHEX has a high affinity for ASARMs, and will cleave these fragments into smaller fragments, thus protecting the nucleation centers and promoting mineralization (12-14). In addition, PHEX will also bind the ASARM sequence in full-length SIBLING molecules (such as MEPE), possibly protecting them from proteolysis (15, 16). This blocks the generation of ASARMs that serve as antagonists to mineralization (15). Human PHEX is a 90-100 kDa, 749 amino acid (aa) type II transmembrane glycoprotein (3, 8, 9, 17). It contains a 20 aa cytoplasmic segment and a 708 aa extracellular region (aa 42-749) that possesses a lengthy catalytic domain (aa 67-741). Multiple point mutations are noted that adversely affect PHEX activity. There is one potential isoform variant that shows a six aa substitution for aa 1-293. Full-length human and mouse PHEX share 96% aa sequence identity.

    • References:
      1. Turner, A.J. et al. (2001) BioEssays 23:261.
      2. Francis, F. et al. (1995) Nat. Genet. 11:130.
      3. Lipman, M.L. et al. (1998) J. Biol. Chem. 273:13729.
      4. Grieff, M. et al. (1997) Biochem. Biophys. Res. Commun. 231:635.
      5. Beck, L. et al. (1997) J. Clin. Invest. 99:1200.
      6. Guo, R. & L.D. Quarles (1997) J. Bone Miner. Res. 12:1009.
      7. Ruchon, A.F. et al. (1998) J. Histochem. Cytochem. 46:459.
      8. Ruchon, A.F. et al. (2000) J. Bone Miner. Res. 15:1440.
      9. Liu, S. et al. (2002) J. Biol. Chem. 277:3686.
      10. Sapir-Koren, R. & G. Livshits (2011) IBMS BoneKEy 8:286.
      11. Gajjeraman, S. et al. (2007) J. Biol. Chem. 282:1193.
      12. Rowe, P.S. (2012) Cell Biochem. Funct. 30:355.
      13. Addison, W.N. et al. (2010) J. Bone Miner. Res. 25:695.
      14. Barros, N. et al. (2013) J. Bone Miner. Res. 28:688.
      15. Cavalli, L. et al. (2012) Clin. Cases Miner. Bone Metab. 9:9.
      16. Rowe, P.S.N. et al. (2005) Bone 36:33.
      17. Liu, S. et al. (2003) J. Biol. Chem. 278:37419.
    • Long Name:
      Phosphate Regulating Endopeptidase Homolog, X-linked
    • Entrez Gene IDs:
      5251 (Human); 18675 (Mouse); 25512 (Rat)
    • Alternate Names:
      EC 3.4.24.-; HPDR; HPDR1; HPDR1X-linked hypophosphatemia protein; HYP1; HYPLXHR; LXHR; Metalloendopeptidase homolog PEX; PEX; PEXVitamin D-resistant hypophosphatemic rickets protein; PHEX; phosphate regulating endopeptidase homolog, X-linked; phosphate regulating gene with homologies to endopeptidases on the X chromosome(hypophosphatemia, vitamin D resistant rickets); phosphate-regulating neutral endopeptidase; XLH
    举报收藏 0评论 0
 
热门项目排行榜快速发布信息
14-(2-碘代乙基)辛基苯 9
2高温波导测试
3格列美脲 98%+ RG  5g
44-溴-3,5-二氯三氟甲苯
5二次谐波
6远红外云试剂
生物试剂排行榜快速发布信息
1Recombinant Human LILR
2Recombinant Human CD47
3Recombinant Human FGF
4203mm具砂板闪式层析柱,
5pUCm-T 载体 5UG
65ml Protein A40 Plus亲
最新加入项目快速发布信息
1质粒大量抽提试剂盒(通
2实验试剂
3产品标题产品标题产品标
4实验试剂
53-Amino-5-methoxycarbo
6N,N-Diethyl-cyclohexan

猜你喜欢产品快速发布信息

相关栏目

还没找到您需要的生物试剂产品?立即发布您的求购意向,让生物试剂公司主动与您联系!

立即发布项目意向

免责声明

本网页所展示的有关【Recombinant Human PHEX Protein, CF 25 UG_生物试剂_云试剂自营四店】的信息/图片/参数等由云试剂的会员【云试剂自营四店】提供,由云试剂会员【云试剂自营四店】自行对信息/图片/参数等的真实性、准确性和合法性负责,本平台(本网站)仅提供展示服务,请谨慎交易,因交易而产生的法律关系及法律纠纷由您自行协商解决,本平台(本网站)对此不承担任何责任。您在本网页可以浏览【Recombinant Human PHEX Protein, CF 25 UG_生物试剂_云试剂自营四店】有关的信息/图片/价格等及提供【Recombinant Human PHEX Protein, CF 25 UG_生物试剂_云试剂自营四店】的商家公司简介、联系方式等信息。

联系方式

在您的合法权益受到侵害时,欢迎您向www@yunshiji.cn邮箱发送邮件,或者进入《网站意见反馈》了解投诉处理流程,我们将竭诚为您服务,感谢您对云试剂的关注与支持!

按排行字母分类找加盟项目:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z